---
title: 'Evaluation of risdiplam efficacy in 5q spinal muscular atrophy: A systematic
  comparison of electrophysiologic with clinical outcome measures'
date: '2023-10-12'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/37823715/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20231012180840&v=2.17.9.post6+86293ac
source: heidelberg[Affiliation]
description: 'CONCLUSIONS: Median nerve CMAP amplitudes increase with risdiplam treatment
  in adult SMA patients, and should be further evaluated as potential easy-to-use
  electrophysiologic markers in assessing and monitoring clinical response to ...'
disable_comments: true
---
CONCLUSIONS: Median nerve CMAP amplitudes increase with risdiplam treatment in adult SMA patients, and should be further evaluated as potential easy-to-use electrophysiologic markers in assessing and monitoring clinical response to ...